CompletedNot Applicable

MyoSure Hysteroscopic Tissue Removal System Registry Study

United States290 participantsStarted 2010-11

Plain-language summary

The objective of this study is to demonstrate the safety and effectiveness of community gynecologist initiated treatment of intra-uterine polyps and submucosal fibroids with the MyoSure Hysteroscopic Tissue Removal System in a significantly sized patient population.

Who can participate

Age range18 Years – 65 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Healthy female between 18 and 65 years of age
✓. Subject must be able to understand, read and sign the study specific informed consent forms after the nature of the study has been fully explained to her
✓. Subject is indicated for myomectomy or polypectomy
✓. Subject exhibits intrauterine polyps and/or submucous myomas which meet one of the following criteria. In cases of subjects with multiple intrauterine pathology, classification is based as follows:

Exclusion criteria

✕. Subject is pregnant
✕. Subject has an Intrauterine Device (IUD) at the time of the procedure. A subject may be enrolled in the study if the IUD is removed prior to the treatment procedure
✕. Subject is taking an anticoagulant or antiplatelet medication other than low dose aspirin
✕. Active pelvic inflammatory disease or pelvic/vaginal infection
✕. Subject has a known or suspected coagulopathy or bleeding disorder
✕. Subject has a history of disease which increases the risk for fluid overload (i.e. significant cardiac, hepatic, or renal dysfunction)
✕. Subject has other co-morbid condition(s) that, in the opinion of the Investigator, could limit the subject's ability to participate in the study or impact the scientific integrity of the study

What they're measuring

Procedure Efficacy

Timeframe: 1 hour post treatment

Trial details

NCT IDNCT01369758

SponsorHologic, Inc.

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2013-05

Results submitted2014-10-23

View on ClinicalTrials.gov More Uterine Fibroids trials